Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion Moving Headquarters to Texas

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion today said that is moving its headquarters from Fremont, Calif., to Austin, Texas.

The molecular diagnostics firm, which emerged from bankruptcy protection earlier this year, said that it will continue to perform R&D, regulatory, and quality operations at its facilities in California. All other functions will be conducted in Austin, where the firm has signed a two-year lease on its new principal place of business.

"This move allows us to take advantage of Austin's strong talent pool and cost-effective environment," Vermillion CEO and Chair of the Board of Directors Gail Page said in a statement. "Austin's central location also facilitates more efficient and effective interaction with our national sales force and our strategic partners on the East Coast, such as Quest Diagnostics and Johns Hopkins University, as well as our colleagues on the West Coast, such as PrecisionMed and Stanford University."

Vermillion expects to complete the move in September 2010.

In early trade on the Nasdaq, Vermillion's shares were unchanged at $10.74.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.